{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:11:40Z","timestamp":1762985500165,"version":"3.45.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["fertstertscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["F&S Science"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.xfss.2020.06.005","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T20:47:55Z","timestamp":1593809275000},"page":"98-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pretreatment with a gonadotropin-releasing hormone agonist and an aromatase inhibitor may improve outcomes in in\u00a0vitro fertilization cycles of women with stage I\u2013II endometriosis"],"prefix":"10.1016","volume":"1","author":[{"given":"Sabrina","family":"Piedimonte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7901-3370","authenticated-orcid":false,"given":"Alexander","family":"Volodarsky-Perel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samer","family":"Tannus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seang Lin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.","family":"Dahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xfss.2020.06.005_bib1","first-page":"270","article-title":"Aromatase inhibitors for endometriosis-associated infertility; do we have sufficient evidence?","volume":"10","author":"Abu Hashim","year":"2016","journal-title":"Int J Fertil Steril"},{"key":"10.1016\/j.xfss.2020.06.005_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/humrep\/dew293","article-title":"World Endometriosis Society consensus on the classification of endometriosis","volume":"32","author":"Johnson","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfss.2020.06.005_bib3","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.fertnstert.2012.08.053","article-title":"Aromatase inhibitors for the treatment of endometriosis","volume":"98","author":"Pavone","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfss.2020.06.005_bib4","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2165\/00003495-200969080-00001","article-title":"Pharmacological treatment of endometriosis: experience with aromatase inhibitors","volume":"69","author":"Ferrero","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.xfss.2020.06.005_bib5","article-title":"Long-term pituitary down-regulation before in\u00a0vitro fertilization (IVF) for women with endometriosis","volume":"1","author":"Sallam","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.xfss.2020.06.005_bib6","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/humrep\/dew148","article-title":"RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF","volume":"31","author":"Decleer","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfss.2020.06.005_bib7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejogrb.2009.02.001","article-title":"Combined down-regulation by aromatase inhibitor and GnRH-agonist in IVF patients with endometriomas\u2014a pilot study","volume":"144","author":"Lossl","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.xfss.2020.06.005_bib8","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.rbmo.2018.12.028","article-title":"A comparison of two months pretreatment with GnRH agonists with or without an aromatase inhibitor in women with ultrasound-diagnosed ovarian endometriomas undergoing IVF","volume":"38","author":"Cantor","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.xfss.2020.06.005_bib9","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/1471-0528.12366","article-title":"The effect of endometriosis on in\u00a0vitro fertilisation outcome: a systematic review and meta-analysis","volume":"120","author":"Harb","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.xfss.2020.06.005_bib10","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.fertnstert.2012.01.112","article-title":"In\u00a0vitro fertilization is a successful treatment in endometriosis-associated infertility","volume":"97","author":"Opoien","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfss.2020.06.005_bib11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/humrep\/deh075","article-title":"High endometrial aromatase P450 mRNA expression is associated with poor IVF outcome","volume":"19","author":"Brosens","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfss.2020.06.005_bib12","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/humrep\/det457","article-title":"ESHRE guideline: management of women with endometriosis","volume":"29","author":"Dunselman","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfss.2020.06.005_bib13","article-title":"Pre and post operative medical therapy for endometriosis surgery","volume":"3","author":"Yap","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.xfss.2020.06.005_bib14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0029-7844(96)00146-9","article-title":"Natural cytotoxicity and GnRH agonist administration in advanced endometriosis: positive modulation on natural killer activity","volume":"88","author":"Garzetti","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xfss.2020.06.005_bib15","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.fertnstert.2008.04.052","article-title":"Interleukin-10 attenuates TNF-alpha-induced interleukin-6 production in endometriotic stromal cells","volume":"91","author":"Tagashira","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfss.2020.06.005_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.fertnstert.2019.03.021","article-title":"Effect of GnRH agonist and letrozole treatment in women with recurrent implantation failure","volume":"112","author":"Steiner","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfss.2020.06.005_bib17","doi-asserted-by":"crossref","first-page":"12519","DOI":"10.1038\/s41598-019-48918-3","article-title":"Evaluation of uterine receptivity after gonadotropin releasing hormone agonist administration as an oocyte maturation trigger: a rodent model","volume":"9","author":"Ezoe","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.xfss.2020.06.005_bib18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/GRF.0000000000000292","article-title":"Medical management of endometriosis","volume":"60","author":"Rafique","year":"2017","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.xfss.2020.06.005_bib19","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.21037\/atm.2019.08.100","article-title":"GnRH agonist and letrozole in women with recurrent implantation failure","volume":"7","author":"Sharma","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.xfss.2020.06.005_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/humupd\/dmi034","article-title":"Aromatase and other steroidogenic genes in endometriosis: translational aspects","volume":"12","author":"Attar","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.xfss.2020.06.005_bib21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/rmb2.12285","article-title":"Local estrogen formation and its regulation in endometriosis","volume":"18","author":"Mori","year":"2019","journal-title":"Reprod Med Biol"},{"key":"10.1016\/j.xfss.2020.06.005_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejogrb.2015.01.009","article-title":"Aromatase inhibitor (anastrozole) affects growth of endometrioma cells in culture","volume":"188","author":"Badawy","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.xfss.2020.06.005_bib23","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1016\/j.fertnstert.2009.08.058","article-title":"Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis","volume":"93","author":"Bilotas","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfss.2020.06.005_bib24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12958-017-0288-8","article-title":"Does daily co-administration of letrozole and gonadotropins during ovarian stimulation improve IVF outcome?","volume":"15","author":"Haas","year":"2017","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.xfss.2020.06.005_bib25","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/humupd\/dmn033","article-title":"Use of letrozole in assisted reproduction: a systematic review and meta-analysis","volume":"14","author":"Requena","year":"2008","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.xfss.2020.06.005_bib26","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/humrep\/der452","article-title":"Endometrial receptivity defects during IVF cycles with and without letrozole","volume":"27","author":"Miller","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfss.2020.06.005_bib27","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/humupd\/4.5.710","article-title":"Expression pattern of integrin adhesion molecules in endometriosis and human endometrium","volume":"4","author":"Regidor","year":"1998","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.xfss.2020.06.005_bib28","first-page":"643","article-title":"Aberrant integrin expression in the endometrium of women with endometriosis","volume":"79","author":"Lessey","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfss.2020.06.005_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.fertnstert.2012.03.055","article-title":"Effect of letrozole on estradiol production and P450 aromatase messenger RNA expression of cultured luteinized granulosa cells from women with and without endometriosis","volume":"98","author":"Lu","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfss.2020.06.005_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13048-017-0341-4","article-title":"Is the oocyte quality affected by endometriosis? A review of the literature","volume":"10","author":"Sanchez","year":"2017","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.xfss.2020.06.005_bib31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.fertnstert.2014.03.053","article-title":"Dynamics of nitric oxide, altered follicular microenvironment, and oocyte quality in women with endometriosis","volume":"102","author":"Goud","year":"2014","journal-title":"Fertil Steril"}],"container-title":["F&S Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666335X20300094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666335X20300094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T21:07:28Z","timestamp":1762981648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666335X20300094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S2666335X20300094"],"URL":"https:\/\/doi.org\/10.1016\/j.xfss.2020.06.005","relation":{},"ISSN":["2666-335X"],"issn-type":[{"type":"print","value":"2666-335X"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pretreatment with a gonadotropin-releasing hormone agonist and an aromatase inhibitor may improve outcomes in in\u00a0vitro fertilization cycles of women with stage I\u2013II endometriosis","name":"articletitle","label":"Article Title"},{"value":"F&S Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xfss.2020.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}